After raising $ 43.5million in Series venture financing , the founders of Homology Medicines have claimed to have created a better understanding of gene editing techniques . The biotech firm is working to replace disease - causing genes with healthy ones in individuals with rare diseases and blood disorders , placing it ahead of gene editing and gene editing measures by recreating natural biological processes . While Homology can list 5AM Ventures and Arch Venture partners as its investors , the company hopes to secure more funding in an effort to create new therapies and continue research into gene editing .
After raising $43.5million in Series A financing, the founders of Homology Medicines have claimed to have created a better version of gene editing methods. The biotech firm is working to replace disease-causing genes with healthy ones in individuals with rare diseases and blood disorders, placing it ahead of gene editing and gene therapy measures by recreating natural biological processes. While Homology can list 5AM Ventures and Arch Venture Partners as its investors, the company hopes to secure more funding in an effort to create new therapies and continue research into gene editing.